Preclinical screening for acute toxicity of therapeutic monoclonal antibodies in a hu-SCID model

Monoclonal antibodies (mAbs) have been a spectacular clinical and commercial success in the treatment of cancer and autoimmune diseases. Many of these mAbs (for example, OKT3, Campath-1H, rituximab and infliximab) are against surface or secreted products of lymphocytes. However, mAbs can have a vari...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Transl Immunology
Huvudupphovsmän: Brady, Jamie L, Harrison, Leonard C, Goodman, David J, Cowan, Peter J, Hawthorne, Wayne J, O'Connell, Philip J, Sutherland, Robyn M, Lew, Andrew M
Materialtyp: Artigo
Språk:Inglês
Publicerad: Nature Publishing Group 2014
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4282178/
https://ncbi.nlm.nih.gov/pubmed/25587392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cti.2014.28
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk